C. Dubost et al. / Tetrahedron 60 (2004) 7693–7704
7703
0.49 mmol, 1 equiv.) in THF (20 ml) was added dropwise a
solution of LiAlH4 (1 M in Et2O, 1.96 ml, 1.96 mmol,
4 equiv.). After completion the mixture was heated at reflux
for 3 h. After cooling to room temperature, the solution was
diluted with 20 ml of Et2O and 30 ml of water. The phases
were separated and the aqueous layer extracted twice with
Et2O. The combined organic phase was dried over MgSO4
and concentrated. The residue was purified by column
chromatography (PE 3/EA 1) to give pure diol 21b as a
colourless oil (75 mg, 65%); 1H NMR (300 MHz, CDCl3) d:
7.38–7.28 (5H, m), 5.03 (1H, bs), 4.98 (1H, bs), 4.64 (1H, d,
J¼11.2 Hz), 4.39 (1H, d, J¼11.2 Hz), 4.17 (1H, d,
J¼5.8 Hz), 3.83 (1H, qd, J¼6.1, 3.1 Hz), 3.53 (1H, dd,
J¼5.8, 3.1 Hz), 1.75 (3H, s), 1.31 (3H, d, J¼6.1 Hz); 13C
NMR (75 MHz, CDCl3) d: 144.72, 137.70, 128.48, 127.93,
112.72, 77.00, 74.64, 73.46, 70.85, 18.48, 15.69; IR (neat,
NaCl) 3439, 3069, 3028, 2975, 2924, 1451, 1131, 1067,
1022, 995, 901, 737 cm21; MS (EI) m/z: 236.3 (Mzþ); Anal.
calcd for C14H20O3: C, 71.16; H, 8.53; found: C, 71.13; H,
8.71.
2.7.8. Syn–syn 2-methyl-1-(2,2,5-trimethyl-1,3-dioxolan-
4-yl)propyl diisopropylcarbamate 28c. Diol 27c (29 mg,
0.10 mmol, 1 equiv.) was mixed with a few crystals of
PTSA in 15 ml of acetone. The mixture was heated at reflux
for 3 h. After cooling, 15 ml of Et2O were added followed
by a saturated aqueous solution of NaHCO3. The phases
were separated and the aqueous layer extracted twice with
Et2O. The combined organic phase was dried over MgSO4
and concentrated to give pure acetonide 28c as a colourless
oil (30 mg, 91%); 1H NMR (300 MHz, CDCl3) d: 4.65 (1H,
dd, J¼8.5, 1.9 Hz), 4.02–3.88 (2H, m), 3.77 (1H, dq, J¼8.5,
5.8 Hz), 3.68 (1H, dd, J¼8.5, 1.9 Hz), 2.08 (1H, hept d,
J¼8.4, 6.6 Hz), 1.39 (3H, s), 1.37 (3H, s), 1.22 (3H, d,
J¼5.8 Hz), 1.22 (12H, m), 0.99 (3H, d, J¼6.9 Hz), 0.95
(3H, d, J¼6.6 Hz); 13C NMR (75 MHz, CDCl3) d: 155.27,
107.69, 81.83, 74.75, 72.93, 46.12–45.55, 30.40, 27.21,
26.91, 29.67–20.56 219.29, 19.16, 17.25; IR (neat, NaCl)
2969, 2933, 2876, 1695, 1435, 1370, 1310, 1221, 1097,
1048, 935, 874, 767 cm21; MS (EI) m/z: 316.3 (MþHþ).
2.7.9. Syn–anti 4-(1-(benzyloxy)ethyl)-2,2-dimethyl-5-
(prop-1-en-2-yl)-1,3-dioxolane 28b. Diol 27b (16 mg,
0.066 mmol, 1 equiv.) was mixed with a few crystals of
PTSA in 5 ml of acetone. The mixture was heated at reflux
for 18 h. After cooling, 20 ml of Et2O were added followed
by a saturated aqueous solution of NaHCO3. The phases
were separated and the aqueous layer extracted twice with
Et2O. The combined organic phase was dried over MgSO4
and concentrated. The residue was purified by column
chromatography (PE/EA¼8/1, Et3N 5%) to give pure
2.7.6. Syn–syn 5-(benzyloxy)-2-methylhex-1-ene-3,4-diol
27d. To a solution of carbamate 26d (84 mg, 0.231 mmol,
1 equiv.) in THF (17 ml) was added dropwise a solution of
LiAlH4 (1 M in Et2O, 0.926 ml, 0.926 mmol, 4 equiv.).
After completion the mixture was heated at reflux for 5 h.
After cooling to room temperature, the solution was diluted
with 20 ml of Et2O and 30 ml of water. The phases were
separated and the aqueous layer extracted twice with
Et2O. The combined organic phase was dried over MgSO4
and concentrated to give pure diol 27d as a colourless oil
1
acetonide 28b as a colourless oil (7 mg, 39%); H NMR
1
(55 mg, 99%); H NMR (300 MHz, CDCl3) d: 7.39–7.27
(300 MHz, CDCl3) d: 7.40–7.23 (5H, m), 4.97 (1H, t,
J¼0.8 Hz), 4.94 (1H, t, J¼1.6 Hz), 4.67 (1H, d, J¼12.1 Hz),
4.62 (1H, d, J¼12.1 Hz), 4.52 (1H, d, J¼6.9 Hz), 4.20 (1H,
dd, J¼8.0, 6.9 Hz), 3.51 (1H, dq, J¼8.0, 6.0 Hz), 1.73 (3H,
s), 1.58 (3H, s), 1.57 (3 h, s), 1.14 (3H, d, J¼6.0 Hz); 13C
NMR (50 MHz, CDCl3) d: 141.94, 139.01, 128.20, 127.67,
127.31, 115.12, 108.63, 82.41, 81.12, 72.99, 71.43, 26.57,
25.12, 19.66, 17.27; IR (neat, NaCl) 2983, 2930, 1451,
1374, 1260, 1212, 1159, 1088, 1045, 874, 735 cm21; MS
(EI) m/z: 276.3 (Mzþ).
(5H, m), 5.00 (1H, bs), 4.96–4.93 (1H, m), 4.68 (1H, d,
J¼11.5 Hz), 4.41 (1H, d, J¼11.5 Hz), 4.08 (1H, d,
J¼3.8 Hz), 3.70 (1H, qd, J¼6.3, 4.1 Hz), 3.46 (1H, bt,
J¼4.1 Hz), 3.11–2.99 (1H, m), 2.69–2.60 (1H, m), 1.74
(3H, s), 1.31 (3H, d, J¼6.3 Hz); 13C NMR (75 MHz,
CDCl3) d: 144.31, 137.75, 128.52, 127.91, 112.73, 75.60,
74.58, 74.84, 70.84, 18.59, 15.79; IR (neat, NaCl) 3428,
3063, 3024, 2975, 2922, 1452, 1137, 1069, 1020, 901,
733 cm21; MS (CI2) m/z: 235.2 (M2H2).
2.7.7. Syn–anti 2-methyl-1-(2,2,5-trimethyl-1,3-dioxo-
lan-4-yl)propyl diisopropylcarbamate 28a. Diol 27a
(54 mg, 0.19 mmol, 1 equiv.) was mixed with a few crystals
of PTSA in 10 ml of acetone. The mixture was heated at
reflux for 5 h. After cooling, 20 ml of Et2O were added
followed by a saturated aqueous solution of NaHCO3. The
phases were separated and the aqueous layer extracted twice
with Et2O. The combined organic phase was dried over
MgSO4 and concentrated. The residue was purified by
column chromatography (PE/EA¼5/1, Et3N 5%) to give
2.7.10. Syn–syn 4-(1-(benzyloxy)ethyl)-2,2-dimethyl-5-
(prop-1-en-2-yl)-1,3-dioxolane 28d. Diol 27d (54 mg,
0.23 mmol, 1 equiv.) was mixed with a few crystals of
PTSA in 20 ml of acetone. The mixture was heated to reflux
for 3 h. After cooling, 10 ml of Et2O were added followed
by a saturated solution of NaHCO3. The phases were
separated and the aqueous layer extracted twice with
Et2O. The combined organic phase was dried over MgSO4
and concentrated. The residue was purified by column
chromatography (PE/EA¼15/1) to give pure acetonide 28d
as a colourless oil (52 mg, 83%); 1H NMR (300 MHz,
CDCl3) d: 7.39–7.24 (5H, m), 4.93–4.91 (2H, m), 4.70 (1H,
d, J¼12.1 Hz), 4.55 (1H, d, J¼12.1 Hz), 4.35 (1H, d,
J¼8.1 Hz), 3.80 (1H, dd, J¼8.3, 4.4 Hz), 3.55 (1H, qd,
J¼6.4, 4.5 Hz), 1.75 (3H, s), 1.45 (3H, s), 1.44 (3 h, s), 1.23
(3H, d, J¼6.4 Hz); 13C NMR (75 MHz, CDCl3) d: 141.97,
139.57, 128.31, 127.85, 127.52, 115.22, 108.91, 82.07,
81.07, 73.33, 71.08, 27.09, 27.03, 17.07, 16.25; IR (neat,
NaCl) 3068, 3033, 2986, 2935, 2871, 1652, 1454, 1372,
1244, 1214, 1154, 1091, 1070, 883, 737 cm21; MS (EI) m/z:
276.2 (Mzþ).
1
pure acetonide 28a as a colourless oil (55 mg, 89%); H
NMR (300 MHz, CDCl3) d: 4.91 (1H, dd, J¼8.5, 3.6 Hz),
4.13 (1H, dq, J¼7.7, 6.0 Hz), 4.02–3.80 (2H, m), 3.61 (1H,
t, J¼8.3 Hz), 2.08 (1H, hept d, J¼6.9, 3.6 Hz),1.40 (3H, s),
1.37 (3H, s), 1.32–1.19 (15H, m), 0.98 (3H, d, J¼6.9 Hz),
0.94 (3H, d, J¼6.9 Hz); 13C NMR (50 MHz, CDCl3) d:
154.60, 108.03, 26.86, 21.48–20.57, 19.28, 18.86, 16.43; IR
(neat, NaCl) 2968, 2936, 2882, 1701, 1430, 1369, 1293,
1215, 1154, 1090, 1048, 985, 858, 766 cm21; MS (CIþ)
m/z: 316.2 (M2Hþ); Anal. calcd for C17H33NO4: C, 64.73;
H, 10.54; N, 4.44; found: C, 64.94; H, 10.51; N, 4.37.